Daily Judi: Tuesday, September 6, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Bloomberg Law reports that CVS Health Corporation, based in Woonsocket, RI, reached a cash-price purchase agreement with Signify Health Inc. for approximately $8 billion.
Meanwhile, Google has joined the global campaign to eradicate tuberculosis, a disease that kills 1.4 million people per year. The search engine giant has developed an AI to detect tuberculosis, most helpful in communities with limited access to radiologists. (STAT)
Fierce Pharma rounds up the latest COVID-19 vaccine news, including two inhaled vaccines that have been given emergency use authorization.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
We also hope to see you this September 13-14, in Boston, for DPHARM: Disruptive Innovations to Advance Clinical Trials, walking distance from our North End headquarters.
Attending the annual conference of the Society for Clinical Data Management in San Antonio, Texas (SCDM2022)? Join AG Mednet's Abraham Gutman in a roundtable discussion on how imaging quality control automation improve endpoint data, Monday, September 12, 2022, 1:45 to 2:45 p.m.
Our Culture
“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”
–Jess, Program Manager
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 110,000 users across 140 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
